NYSE · Drug Manufacturers - General

Johnson & Johnson (JNJ)

$270.24 +1.07%
Add alert
62 In band Daily RSI (14) · 21 Aug 2026

Moving averages

SMA 50$254.83+6.05%
SMA 200$228.39+18.32%
EMA 20$262.56+2.93%

Company profile

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.

SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$630.94B
P/E ratio30.02
EPS$8.72
Beta0.231
Dividend yield2.02%
52-week high$274.90
52-week low$168.47

Insider transactions

ExecutiveTitleActionSharesDate
DUATO, JOAQUINDirector, CEO and Chairman of the BoardBuy123,2912026-08-13
DUATO, JOAQUINDirector, CEO and Chairman of the BoardSell123,2912026-08-13
DUATO, JOAQUINDirector, CEO and Chairman of the BoardSell102,3152026-08-13
Continue with Google
Unlock insider transactions

Latest news

Scientists beat Johnson & Johnson in fight over talc cancer research
Neutral Gulf News 2 days ago
Starling Oncology secures $25M revolving credit line for working capital | Dealroom.co
Somewhat-Bullish Dealroom 2 days ago
Mckesson Corp Stock (MCK) Moved Up by 3.13% on Aug 21: A Full Analysis
Somewhat-Bullish TradingKey 3 days ago

Earnings call transcript

Q2 2026

Good morning. Welcome to Johnson & Johnson's second quarter 2026 earnings conference call. All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being recorded. If anyone has any objections, you may disconnect at this time. If you experience technical difficulties during the conference, you may press star zero to reach the operator. I will now turn the conference call over to Ryan Kurz from Johnson & Johnson. You may begin.…

Continue with Google
Unlock the earnings call transcript

Options chain

TypeStrikeExpiryVolumeOpen interest
Put$220.002026-09-183,1894,768
Put$260.002026-10-162,674484
Put$240.002026-09-181,4663,516
Continue with Google
Unlock the options chain

Similar stocks in Drug Manufacturers - General

PFE Pfizer Inc RSI 72 LLY Lilly(Eli) & Company RSI 60 BMY Bristol-Myers Squibb Company RSI 63 MRK Merck & Co Inc RSI 78 NVO Novo Nordisk RSI 50 ABBV Abbvie Inc RSI 64 GILD Gilead Sciences Inc RSI 67 AMGN AMGEN Inc RSI 74 GSK GSK Plc RSI 56 OGN Organon & Company RSI 75
Free forever

RSI alerts for JNJ

Get an email the moment Johnson & Johnson crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 24 August 2026 at 12:28 AM EDT